North America Allergy Immunotherapies Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Allergy Immunotherapies Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Allergy Immunotherapies Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Allergy Immunotherapies Market Regional Analysis

6.2 North America Allergy Immunotherapies Market Revenue 2017-2027 (US$ Million)

6.3 North America Allergy Immunotherapies Market Forecast Analysis

7. North America Allergy Immunotherapies Market Analysis – by Treatment

7.1 Subcutaneous Immunotherapy

7.1.1 Overview
7.1.2 Subcutaneous Immunotherapy: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Sublingual Immunotherapy

7.2.1 Overview
7.2.2 Sublingual Immunotherapy: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Allergy Immunotherapies Market Analysis – by Allergy type

8.1 Allergic Rhinitis

8.1.1 Overview
8.1.2 Allergic Rhinitis: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Asthma

8.2.1 Overview
8.2.2 Asthma: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Food Allergy

8.3.1 Overview
8.3.2 Food Allergy: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Venom Allergy

8.4.1 Overview
8.4.2 Venom Allergy: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Allergy Immunotherapies Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Hospital Pharmacy: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Retail Pharmacy

9.2.1 Overview
9.2.2 Retail Pharmacy: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Online Pharmacy

9.3.1 Overview
9.3.2 Online Pharmacy: North America Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Allergy Immunotherapies Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Allergy Immunotherapies Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 North America Allergy Immunotherapies Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 US: North America Allergy Immunotherapies Market Breakdown, by Treatment
10.2.1.1.2 US: North America Allergy Immunotherapies Market Breakdown, by Allergy type
10.2.1.1.3 US: North America Allergy Immunotherapies Market Breakdown, by Distribution Channel

10.2.1.2 Canada: North America Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Canada: North America Allergy Immunotherapies Market Breakdown, by Treatment
10.2.1.2.2 Canada: North America Allergy Immunotherapies Market Breakdown, by Allergy type
10.2.1.2.3 Canada: North America Allergy Immunotherapies Market Breakdown, by Distribution Channel

10.2.1.3 Mexico : North America Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Mexico : North America Allergy Immunotherapies Market Breakdown, by Treatment
10.2.1.3.2 Mexico : North America Allergy Immunotherapies Market Breakdown, by Allergy type
10.2.1.3.3 Mexico : North America Allergy Immunotherapies Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Johnson and Johnson Services, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 ALK Abello A/S

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Aimmune Therapeutics

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Anergis

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Circassia

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Allergy Immunotherapies Market

Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Geography